All terms in GO
| Label | Id | Description |
|---|---|---|
| negative regulation of cellular response to thapsigargin | GO_1905892 | [Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to thapsigargin.] |
| negative regulation of cellular response to tunicamycin | GO_1905895 | [Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to tunicamycin.] |
| positive regulation of cellular response to tunicamycin | GO_1905896 | [Any process that activates or increases the frequency, rate or extent of cellular response to tunicamycin.] |
| macromolecule deacylation | GO_0098732 | [The removal of an acyl group, any group or radical of the form RCO- where R is an organic group, from a macromolecule.] |
| fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell | GO_0035602 | [The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands, which stops, prevents, or reduces the frequency, rate or extent of the occurrence or rate of cell death by apoptotic process in the bone marrow.] |
| negative regulation of apoptotic process in bone marrow cell | GO_0071866 | [Any process that stops, prevents, or reduces the frequency, rate or extent of the occurrence or rate of cell death by apoptotic process in the bone marrow.] |
| tRNA methylthiolation | GO_0035600 | [The addition of a methylthioether group (-SCH3) to a nucleotide in a tRNA molecule.] |
| peptidyl-cysteine S-nitrosylase activity | GO_0035605 | [Catalysis of the transfer of a nitric oxide (NO) group to a sulphur atom within a cysteine residue of a protein.] |
| transferase activity, transferring nitrogenous groups | GO_0016769 | [Catalysis of the transfer of a nitrogenous group from one compound (donor) to another (acceptor).] |
| peptidyl-cysteine S-trans-nitrosylation | GO_0035606 | [Transfer of a nitric oxide (NO) group from one cysteine residue to another.] |
| fibroblast growth factor receptor signaling pathway involved in hemopoiesis | GO_0035603 | [The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands, which contributes to hemopoiesis.] |
| fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow | GO_0035604 | [The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands, which activates or increases the frequency, rate or extent of cell proliferation in the bone marrow.] |
| positive regulation of cell proliferation in bone marrow | GO_0071864 | [A process that activates or increases the frequency, rate or extent of cell proliferation in the bone marrow.] |
| C-terminal protein deglutamylation | GO_0035609 | [The removal of a C-terminal, gene-encoded glutamate residue from a protein.] |
| protein deglutamylation | GO_0035608 | [The removal of a glutamate residue from a protein. Glutamate residues in proteins can be gene-encoded, or added as side chains during the protein modification process of polyglutamylation.] |
| fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development | GO_0035607 | [The series of molecular signals generated as a consequence of a fibroblast growth factor-type receptor binding to one of its physiological ligands, which contributes to the progression of the orbitofrontal cortex over time from its initial formation until its mature state.] |
| peptidyl-glutamic acid modification | GO_0018200 | [The modification of peptidyl-glutamic acid.] |
| GO_0035620 | GO_0035620 | |
| renal glucose absorption | GO_0035623 | [A renal system process in which glucose is taken up from the collecting ducts and proximal and distal loops of the nephron. In non-mammalian species, absorption may occur in related structures.] |
| receptor transactivation | GO_0035624 | [The process in which a receptor is activated by another receptor. Receptor transactivation can occur through different mechanisms and includes cross-talk between signaling pathways where one receptor activates a receptor for a different ligand, and also activation of subunits within a receptor oligomer.] |